Clinical trial
Efficacy Of Switching From SSRI to Desvenlafaxine on Cognitive Function In Patients With an Acute Episode of Major Depression
NCT03432221 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Of Switching From SSRI to Desvenlafaxine on Cognitive Function In Patients With an Acute Episode of Major Depression
- Lead sponsor
- Corporacion Parc Tauli
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 3, 2018
- Completion date
- June 3, 2019
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.